Axa’s DONNELLEY R R & SONS CO DNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-122,800
Closed -$1.93M 1334
2016
Q3
$1.93M Buy
122,800
+121,000
+6,722% +$1.9M 0.01% 765
2016
Q2
$30K Sell
1,800
-600
-25% -$10K ﹤0.01% 1316
2016
Q1
$39K Sell
2,400
-97,900
-98% -$1.59M ﹤0.01% 1258
2015
Q4
$1.48M Buy
100,300
+85,200
+564% +$1.25M 0.01% 843
2015
Q3
$220K Buy
+15,100
New +$220K ﹤0.01% 1196
2015
Q2
Sell
-39,700
Closed -$762K 1535
2015
Q1
$762K Buy
+39,700
New +$762K ﹤0.01% 1011

Other funds holding DNY

Axa's DNY Position: Q4 2016 in Review

Axa sold out of DONNELLEY R R & SONS CO (DNY) in Q4 2016, closing a stake of 122,800 shares — an estimated $1.93M sold.

Axa first reported a position in DNY in Q1 2015 and held it in 6 quarters. The position peaked at $1.93M in Q3 2016. 6 funds tracked by Wall St. Rank hold DNY as of Q4 2016.

  • Axa reported no remaining DONNELLEY R R & SONS CO position as of Q4 2016 after selling out during the quarter.
  • Axa sold 122,800 DONNELLEY R R & SONS CO shares in Q4 2016, an estimated $1.93M.
  • Axa first reported a position in DONNELLEY R R & SONS CO in Q1 2015 and held it in 6 quarters.
  • Axa's DONNELLEY R R & SONS CO position peaked at $1.93M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held DONNELLEY R R & SONS CO as of Q4 2016.

Based on Axa's 13F filing for Q4 2016, filed 13 Feb 2017.